251 related articles for article (PubMed ID: 15950992)
21. High expression of a new marker PCA-1 in human prostate carcinoma.
Konishi N; Nakamura M; Ishida E; Shimada K; Mitsui E; Yoshikawa R; Yamamoto H; Tsujikawa K
Clin Cancer Res; 2005 Jul; 11(14):5090-7. PubMed ID: 16033822
[TBL] [Abstract][Full Text] [Related]
22. A novel method of obtaining prostate tissue for gene expression profiling.
Sooriakumaran P; Henderson A; Denham P; Langley SE
Int J Surg Pathol; 2009 Jun; 17(3):238-43. PubMed ID: 18508841
[TBL] [Abstract][Full Text] [Related]
23. Tissue microarrays: applications in genomic research.
Watanabe A; Cornelison R; Hostetter G
Expert Rev Mol Diagn; 2005 Mar; 5(2):171-81. PubMed ID: 15833047
[TBL] [Abstract][Full Text] [Related]
24. Functional genomics of hepatocellular carcinoma.
Thorgeirsson SS; Lee JS; Grisham JW
Hepatology; 2006 Feb; 43(2 Suppl 1):S145-50. PubMed ID: 16447291
[TBL] [Abstract][Full Text] [Related]
25. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
Ohori M
Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
[TBL] [Abstract][Full Text] [Related]
26. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
Schlomm T; Luebke AM; Sültmann H; Hellwinkel OJ; Sauer U; Poustka A; David KA; Chun FK; Haese A; Graefen M; Erbersdobler A; Huland H
Int J Oncol; 2005 Sep; 27(3):713-20. PubMed ID: 16077921
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling as a tool for basic analysis and clinical application of human cancer.
García-Escudero R; Paramio JM
Mol Carcinog; 2008 Aug; 47(8):573-9. PubMed ID: 18324660
[TBL] [Abstract][Full Text] [Related]
28. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
[TBL] [Abstract][Full Text] [Related]
29. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.
Lin DW; Coleman IM; Hawley S; Huang CY; Dumpit R; Gifford D; Kezele P; Hung H; Knudsen BS; Kristal AR; Nelson PS
J Clin Oncol; 2006 Aug; 24(23):3763-70. PubMed ID: 16822846
[TBL] [Abstract][Full Text] [Related]
30. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
Kulasingam V; Diamandis EP
Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
34. [A modern method for differential gene expression analysis and its significance for cancer diagnostics and therapy].
Pospísilová S; Mayer J
Cas Lek Cesk; 2005; 144(1):11-7; discussion 18. PubMed ID: 15789776
[TBL] [Abstract][Full Text] [Related]
35. Emerging biomarker technologies.
Gunn L; Smith MT
IARC Sci Publ; 2004; (157):437-50. PubMed ID: 15055310
[TBL] [Abstract][Full Text] [Related]
36. Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profiling.
Berzsenyi MD; Roberts SK; Beard MR
Antivir Ther; 2006; 11(5):541-52. PubMed ID: 16964821
[TBL] [Abstract][Full Text] [Related]
37. Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
Morgenbesser SD; McLaren RP; Richards B; Zhang M; Akmaev VR; Winter SF; Mineva ND; Kaplan-Lefko PJ; Foster BA; Cook BP; Dufault MR; Cao X; Wang CJ; Teicher BA; Klinger KW; Greenberg NM; Madden SL
Prostate; 2007 Jan; 67(1):83-106. PubMed ID: 17013881
[TBL] [Abstract][Full Text] [Related]
38. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
39. Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens.
Li HR; Wang-Rodriguez J; Nair TM; Yeakley JM; Kwon YS; Bibikova M; Zheng C; Zhou L; Zhang K; Downs T; Fu XD; Fan JB
Cancer Res; 2006 Apr; 66(8):4079-88. PubMed ID: 16618727
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling in acute myeloid leukemia.
Bullinger L; Valk PJ
J Clin Oncol; 2005 Sep; 23(26):6296-305. PubMed ID: 16155012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
